# Blood Glucose Response of Novel Wild Rice Enhanced Food Products (Trial 2)

> **NCT06498024** · NA · WITHDRAWN · sponsor: **Dylan MacKay**

## Conditions studied

- Blood Glucose

## Interventions

- **OTHER:** Kellogg's - rice krispies (control)
- **OTHER:** Kellogg's - rice krispies (control) + 125ml milk
- **OTHER:** Novel cereal (40% Canadian wild rice, 60% fava bean blend) + 125 ml milk
- **OTHER:** Novel cereal (40% Canadian wild rice, 60% fava bean blend)
- **OTHER:** Novel cereal (40% Canadian wild rice, 50% fava bean blend) + 10% purple powder (sweet potato)
- **OTHER:** Novel cereal (40% Canadian wild rice, 50% fava bean blend) + 10% purple powder (sweet potato) + 125 ml milk

## Key facts

- **NCT ID:** NCT06498024
- **Lead sponsor:** Dylan MacKay
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-09-01
- **Primary completion:** 2026-03-30
- **Final completion:** 2026-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The wild rice cereal development was stopped, so the trial was also withdrawn prior to starting.
- **Last updated:** 2025-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06498024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06498024, "Blood Glucose Response of Novel Wild Rice Enhanced Food Products (Trial 2)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06498024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*